Abstract
The development of new delivery systems for the controlled release of drugs is one of the most interesting fields of research in pharmaceutical sciences. Microparticles can be used for the controlled release of drugs, vaccines, antibiotics, and hormones. To prevent the loss of encapsulated materials, the microcapsules should be coated with another polymer that forms a membrane on the surface. In addition there are several fundamental properties of polymers that are useful in solving drug delivery problems, as they can be combined with the drug covalently or ionically to overcome problems like solubility, stability or permeability. Chitosan is a copolymer of N-acetylglucosamine and glucosamine derived from chitin, which is extracted from crustaceans ’ shells. This polymer has become the focus of major interest in recent years because it has applications in several fields such as biomedicine, agriculture, the textile industry and the paper industry. There are many processes that can be used to encapsulate drugs within chitosan matrixes such as ionotropic gelation, spray drying, emulsification- solvent evaporation and coacervation. Combinations of these processes are also used in order to obtain microparticles with specific properties and performances. This review provides an overview of these four techniques applied directly to chitosan microparticulate systems.
Keywords: Chitosan, controlled release systems, ionotropic gelation, spray drying, emulsification- solvent evaporation, coacervation
Current Drug Discovery Technologies
Title: New Drug Delivery Systems Based on Chitosan
Volume: 5 Issue: 4
Author(s): Ines Panos, Niuris Acosta and Angeles Heras
Affiliation:
Keywords: Chitosan, controlled release systems, ionotropic gelation, spray drying, emulsification- solvent evaporation, coacervation
Abstract: The development of new delivery systems for the controlled release of drugs is one of the most interesting fields of research in pharmaceutical sciences. Microparticles can be used for the controlled release of drugs, vaccines, antibiotics, and hormones. To prevent the loss of encapsulated materials, the microcapsules should be coated with another polymer that forms a membrane on the surface. In addition there are several fundamental properties of polymers that are useful in solving drug delivery problems, as they can be combined with the drug covalently or ionically to overcome problems like solubility, stability or permeability. Chitosan is a copolymer of N-acetylglucosamine and glucosamine derived from chitin, which is extracted from crustaceans ’ shells. This polymer has become the focus of major interest in recent years because it has applications in several fields such as biomedicine, agriculture, the textile industry and the paper industry. There are many processes that can be used to encapsulate drugs within chitosan matrixes such as ionotropic gelation, spray drying, emulsification- solvent evaporation and coacervation. Combinations of these processes are also used in order to obtain microparticles with specific properties and performances. This review provides an overview of these four techniques applied directly to chitosan microparticulate systems.
Export Options
About this article
Cite this article as:
Panos Ines, Acosta Niuris and Heras Angeles, New Drug Delivery Systems Based on Chitosan, Current Drug Discovery Technologies 2008; 5 (4) . https://dx.doi.org/10.2174/157016308786733528
DOI https://dx.doi.org/10.2174/157016308786733528 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vasculitis Beyond the Kidneys
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Neuronal Differentiation of Neural Progenitor Cells by Intracellular Delivery of Synthetic Oligopeptide Derived from Von Hippel-Lindau Protein
Protein & Peptide Letters Physical Activity, Insulin Action, and Diabetes Prevention and Control
Current Diabetes Reviews Updated Acute Community-Acquired Pneumonia in Adults: Guidelines for Initial Antimicrobial Therapy Based on Local Evidence from the South American Working Group (Consensur II)
Current Respiratory Medicine Reviews The Mineralocorticoid Receptor in Endothelial Physiology and Disease: Novel Concepts in the Understanding of Erectile Dysfunction
Current Pharmaceutical Design Can Statins Prevent Progression of Degenerated Aortic Valve Stenosis?
Vascular Disease Prevention (Discontinued) Editorial [Hot Topic: Natural Products for the Healthy Heart (Guest Editor : Dipak K. Das)]
Current Pharmaceutical Biotechnology Co-morbidity of Diabetes Mellitus and Orodental Diseases in Nigeria
Current Diabetes Reviews Targeting Metallothionein for Prognosis and Treatment of Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Chitosan-based Nano-biocomposites and their Applications in Medicine and Pharmaceutics
Current Organic Chemistry Requirements and Perspectives for Integrating Metabolomics with other Omics Data
Current Metabolomics Editorial [ Hot Topic:The Medicinal Chemistry of New Agents to Treat Diabetes and Obesity (Guest Editor: Jie-Fei Cheng)]
Current Topics in Medicinal Chemistry Amino Acids as Pharmaco-Nutrients for the Treatment of Type 2 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cyclophilin A: A Predictive Biomarker of Carotid Stenosis in Cerebral Ischemic Stroke
Current Neurovascular Research Refining Genetic Approaches for Identifying Behavioral Loci
Current Genomics The Use of L-Glucose in Cancer Diagnosis: Results from In Vitro and In Vivo Studies
Current Medicinal Chemistry Liver Disease in Diabetes Mellitus: Potential Therapeutic Value of Vitamin E-Silybin Phytosomal Complex
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy
Current Pharmacogenomics Review of Characteristics, Pharmacology, Determination and Pharmacokinetics of Rhaponticin
Mini-Reviews in Organic Chemistry